Terlipressin or norepinephrine, or both in septic shock?
File(s)ICM Editorial 25 June 2018[updated].doc (171 KB)
Accepted version
Author(s)
Mårtensson, Johan
Gordon, AC
Type
Journal Article
Date Issued
2018-11
Date Acceptance
2018-06-29
Citation
Intensive Care Medicine, 2018, 44 (11), pp.1964-1966
ISSN
0342-4642
Publisher
Springer Verlag
Start Page
1964
End Page
1966
Journal / Book Title
Intensive Care Medicine
Volume
44
Issue
11
Copyright Statement
© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018. The final publication is available at Springer via https://link.springer.com/article/10.1007%2Fs00134-018-5290-x
Sponsor
National Institute for Health Research
National Institute for Health Research
Identifier
https://link.springer.com/article/10.1007%2Fs00134-018-5290-x
Grant Number
NIHR/CS/009/007
NIHR Fellowship
Subjects
Science & Technology
Life Sciences & Biomedicine
Critical Care Medicine
General & Internal Medicine
VASOPRESSIN
INFUSION
TRIAL
Hemodynamics
Humans
Norepinephrine
Shock, Septic
Terlipressin
Vasoconstrictor Agents
Humans
Shock, Septic
Norepinephrine
Vasoconstrictor Agents
Hemodynamics
Terlipressin
Emergency & Critical Care Medicine
1103 Clinical Sciences
1117 Public Health and Health Services
Publication Status
Published
Date Publish Online
2018-07-13